Wohlfahrtiimonas chitiniclastica: current insights into an emerging human pathogen

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • P Schröttner - , Institut für Klinische Chemie und Laboratoriumsmedizin, Medizinische Fakultät Carl Gustav Carus Dresden (Autor:in)
  • W W Rudolph - , Institut für Medizinische Mikrobiologie und Virologie (Autor:in)
  • U Damme - , Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • C Lotz - , Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • E Jacobs - , Institut für Medizinische Mikrobiologie und Virologie (Autor:in)
  • F Gunzer - , Institut für Medizinische Mikrobiologie und Virologie (Autor:in)

Abstract

Since the first description of Wohlfahrtiimonas chitiniclastica in 2008, a number of well described case reports demonstrating its pathogenic role in humans have been published. Infections may be closely linked to flies, such as Wohlfahrtia magnifica, Lucilia sericata, Chrysomya megacephala or Musca domestica. These insects are potent vectors for the distribution of W. chitiniclastica causing local or systemic infections originating from wounds infested with fly larvae. However, other potential sources of transmission of W. chitiniclastica have been described such as soil or chicken meat. Infections in humans reported to date comprise wound infections, cellulitis, osteomyelitis and sepsis. This review summarizes all the literature available up to now and gives the current knowledge about this emerging human pathogen. Additionally, four patients with proven W. chitiniclastica infections treated at Dresden University Hospital between 2013 and 2015, are included. Special focus was placed on microbiological identification and antibiotic susceptibility testing of the pathogen.

Details

OriginalspracheEnglisch
Seiten (von - bis)1292-1303
Seitenumfang12
FachzeitschriftEpidemiology and infection
Jahrgang145
Ausgabenummer7
PublikationsstatusVeröffentlicht - Mai 2017
Peer-Review-StatusJa

Externe IDs

PubMedCentral PMC9203347
Scopus 85011632779

Schlagworte

Schlagwörter

  • Animals, Anti-Bacterial Agents/pharmacology, Gammaproteobacteria/drug effects, Germany, Gram-Negative Bacterial Infections/drug therapy, Humans, Microbial Sensitivity Tests